|
| |
Overview
Financial Highlight
HeadlinesBusiness Background Duopharma Biotech Berhad, an investment holding company, manufactures, distributes, and imports pharmaceutical products and medicines in Malaysia. The company provides products in various forms, including tablets, capsules, syrups, oral antibiotics, creams, hemodialysis solutions, sterile irrigation solutions, sterile powder and small volume injectable forms, dental cartridges, and eye drop preparations. It offers generic and halal pharmaceutical products; and over-the-counter products primarily under the Champs, Flavettes, Proviton, Naturalle, Uphamol, Eye Glo, Donna, and Alucid brands, as well as analgesics, antihistamines, etc. The company also operates under the OMESEC brand name. In addition, it is also involved in the property management activities; and distribution of chemical products. Duopharma Biotech Berhad also exports its products to Vietnam, Ethiopia, Sudan, Southeast Asia, Papua New Guinea, Pakistan, Bangladesh, Sri Lanka, the Republic of Yemen, Singapore, and Hong Kong. The company was formerly known as CCM Duopharma Biotech Berhad and changed its name to Duopharma Biotech Berhad in February 2019. The company was founded in 1979 and is based in Klang, Malaysia. Duopharma Biotech Berhad is a subsidiary of Permodalan Nasional Berhad.
  Secret i bought since 4. And Cd 0.2++. Cd already loss almost 40k. This is the most expensive lesson 21/03/2021 3:08 PM Trevor777 Yes, many were fooled by bicycle man. Acquisition of vaccines not through Middlemen? What is Solution doing with 3.5 million Cansino? Even when they don't have a plant? 21/03/2021 5:47 PM Michael Tan European micronation San Marino begins administering Russia’s Sputnik V vaccine Philippines to receive 3M doses of Sputnik V vaccine from EUA grant Indian drugmaker to produce 200 million doses of Russia’s Sputnik V More and more acceptance over the world... Malaysia soon 22/03/2021 1:05 AM Trevor777 @Michael, ...and what has that to do with Dpharma currently? Chinese vaccine SinoVac can be NPRA approved and shooting into arms but Sputnik V is still on drawing board? And Dpharma is only bottling 6.4 million doses, can this double or triple the price value from original March 2020 at RM1.56? The prospect to look forward is Gemalaya agrees to co-operate and transfer of technology in a JV with Dpharma for Vaccine manufacturing, creating Malaysia as a production hub. This could possible be in 2022, and not contributing any extraordinary profits in 2021. Many are stuck at penthouse price and fooled by bicycle man, thinking that only the 2 Pharmaceutical GLCs would greatly benefits and assist Malaysia at the same time. 22/03/2021 6:39 AM Trevor777 When the price dropped from 3.80 to 3.50, some people alerted the price is going down to 2.00 and we laughed at them....who has the last laugh? Joke is on us to be holding in high valuation. Here we are after -1.00 and at 2.60, hoping for a big break again....second joke. Leonard is all talk but no action. It would take much more than words to get positive results. Academician are never businessmen. And politicians' words taken with a truck of salt. 22/03/2021 6:40 AM  Keyman188 @Trevor777...Thank you for your support Keyman188 prospective on the counter... Keyman188 already highlighted so many time since Dec'20 until Jan'21... Seem like a lot of newbies felt Keyman188 talk cock or "blow water never wipe mouth"... You all had seen Jan'21 comments ???... So what is the price range now ??? Is it almost matching with Keyman188 prediction???... Keyman188 once again to highlight, if upcoming quarterly result unable to growth further, very high possibility anytime shall be neutralised between 1.80 ~ 2.00.... Please spend some time to review past 2 quarterly report... Keyman188 still casualty to review this company but Keyman188 will not invest 1st either upcoming quarterly result can indicate further growth or until the share price to be neutralised... Posted by Keyman188 > Jan 1, 2021 9:08 PM | Report Abuse Keyman188 always like to repeat & repeat to remind market again... Time to wake up switching to economy recovery stocks... Smart money already gone & had switched to others.... Keyman188 foresee further downside risk towards 2.80 ~ 3.00...... If unable to support, further downside risk towards 2.55 ~ 2.65... Don't be hero to fight current level...... Even though you all plan to keep it for long term... But not at this point since overall this counter sentiment remained very very weak... Don't burnt your hard earned money...... For more safety margin better be more patience until below 3.00 then decide again...... Fyi, for the past few years record range, 1.30 ~ 1.60..... Only this year is different because of heading more speculation then shot up above 4.00...... ---------------------------------------------------------------------------------------------------------- Posted by Keyman188 > Dec 15, 2020 2:20 PM | Report Abuse Keyman188 wants to see if the share price drop back to the range 2.00 ~ 2.30 for the next 12 month...then ding dong ding dong this range another 2 /3 years.... wkwkwk...wkwkwk..kekeke...kekeke..... 22/03/2021 7:13 AM Aurora13 Back to normal price... Anyway it shldnt have had gone up at the first place... Lol 30/03/2021 10:28 PM Trevor777 This is what's wrong........the U-turn gets bigger.....so who needs GLCs Pharmaceuticals anymore? https://www.msn.com/en-my/news/national/hasten-approval-of-new-vaccines-putrajaya-told/ar-BB1f8Eoe?li=BBr8Mk9 01/04/2021 8:34 AM Michael Tan Russia’s Sputnik V formula could be updated to protect against new coronavirus variants in just two days using new gene technology www.google.com/amp/s/www.rt.com/russia/519926-sputnik-formula-update-gene-technology/amp/ 02/04/2021 9:07 PM maney Vaccination is free for Msians / foreigners here even if go private hospitals/ clinics/ pharma. All paid by gov. Profit margin won’t be great. 04/04/2021 6:44 PM nokia8250 Come on la, realistic la a bit. TP8 coming. Please. Sounds like a child making comment. 05/04/2021 1:14 PM btuscy @godofgambler, as ur name suggested, u think this playing roulette? TP8? lol 05/04/2021 1:47 PM DrLimKH that's why...UCrest is pleased to announce that the Company has on 9 April 2021, entered into a MOU with RDIF for management of manufacturing of Sputnik V 09/04/2021 7:39 PM fengpinglangjin ucrest manage production sell to rdif..rdif sell to duopharma...ucrest n rdif will earn the big money... 10/04/2021 7:22 AM fengpinglangjin Ucrest find manufacturer ...rfid wil transfer tech....so basically ucrest appoint who who will be manufacturer.... 10/04/2021 9:42 AM Trevor777 IT Software company can be pharmaceutical supplier...WOW! Malaysia Bolih. No wonder the Vaccine registration is lacking far behind. You'll never know what is shot into your arms next. Look at Solution, Kanger and Bintai...goreng with MOU, LOI... plant also don't have. How to manufacture? How long to set up? How about the costs? And the gestation period to completion? No wonder Bursa is for easy come, easy go money. And with a bought Oxford degree...apa pun bolih, u-turn easy on bicycle. 10/04/2021 10:42 AM Trevor777 This is also partly to put blame on RFID, for they see money more than their partners. Green color of money is better looking that the multi-colored suits and red noses on their partners. 10/04/2021 10:46 AM Trevor777 Wonder what's the meaning of 885,300 done at 2.88 (day's top buying volume) and at last 9 minutes before closing? 14/04/2021 5:06 PM Michael Tan RDIF, GL RAPHA AND ISU ABXIS TO COOPERATE FOR PRODUCTION OF SPUTNIK V IN KOREA 16/04/2021 1:38 AM nicholas99 what the . dpharma is doing? Sputnik inks deal with UCREST to mass produce.. sputnik V.. 16/04/2021 12:23 PM  | | ||||||||||||||||||||||||||||||||||||||||||||||||
